The NBA season is nearly underway, and the Oklahoma City Thunder look poised to become the first team since the Golden State Warriors in 2018 to win back-to-back titles. Of course, there are 29 other teams looking to ensure that ...
Perhaps it’s folly to read too much into one Sunday, but the apparent problems of the Eagles and Chiefs don’t seem so major anymore. Two prominent coaches got payback against their former teams Sunday. Is Drake Maye making Patriots fans ...
Customers of the athletic shoe company On have filed a class action lawsuit alleging that some of the brand’s sneakers squeak embarrassingly loudly when they walk. The class action suit, filed in the U.S. district court in Portland — where On’s ...
TORONTO — Trey Yesavage will climb a big league mound for just the sixth time when he starts Game 6 of the American League Championship Series on Oct. 18, the Toronto Blue Jays’ season riding on his 22-year-old arm. Yet ...
TORONTO – Some 24 hours after shaking the city of Seattle with one swing of lumber, Eugenio Suárez was still sorting through the hundreds of text messages from family and friends amazed and inspired by his go-ahead grand slam that ...
Another SEC loss should make this a crisis point for LSU and coach Brian Kelly’s underwhelming tenure. The Commodores are 6-1 for the first time in 75 years and in the thick of the College Football Playoff conversation. LSU can ...
Expectations were raised for Arch Manning after he had arguably his best performance last week against Oklahoma. However, Manning struggled in No. 17 Texas’ 16-13 win over Kentucky in Week 8 on Saturday, Oct. 18 at Kroger Field in Lexington, Kentucky. ...
Kalen DeBoer dressed in his black assassin’s hoodie, and Alabama zapped another ranked opponent. This time, Tennessee fell victim. If Ty Simpson keeps playing like this, he’ll be a Heisman Trophy finalist. Interception swings game to Alabama. TUSCALOOSA, Ala. – ...
Vince Lanci of Echobay Partners explains what’s driving silver’s record-setting price run. According to Lanci, who is also a professor at the University of Connecticut and publisher of the GoldFix newsletter on Substack, the London market is facing a liquidity ...
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application submission with the FDA. New data from the ARCHER trial, highlighting the magnitude of reduction in left ...